Application of a Biphasic Mathematical Model of Cancer Cell Drug Response for Formulating Potent and Synergistic Targeted Drug Combinations to Triple Negative Breast Cancer Cells

Triple negative breast cancer is a collection of heterogeneous breast cancers that are immunohistochemically negative for estrogen receptor, progesterone receptor, and ErbB2 (due to deletion or lack of amplification). No dominant proliferative driver has been identified for this type of cancer, and...

Descripción completa

Detalles Bibliográficos
Autores principales: Shen, Jinyan, Li, Li, Howlett, Niall G., Cohen, Paul S., Sun, Gongqin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7281712/
https://www.ncbi.nlm.nih.gov/pubmed/32349331
http://dx.doi.org/10.3390/cancers12051087

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7281712/
https://www.ncbi.nlm.nih.gov/pubmed/32349331
http://dx.doi.org/10.3390/cancers12051087

Ejemplares similares